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Abstract 
Although research supports the efficacy of exposure therapy for PTSD, some evidence suggests 
that exposure is under-utilized in general clinical practice. The purpose of this study was to 
assess licensed psychologists’ use of imaginal exposure for PTSD and to investigate perceived 
barriers to its implementation. A total of 852 psychologists from 3 states were randomly selected 
and surveyed. An additional 50 members of a trauma special interest group of a national 
behavior therapy organization were also surveyed. The main survey results indicate that a large 
majority of licensed doctoral level psychologists do not report use of exposure therapy to treat 
patients with PTSD. Although approximately half of the main study sample reported that they 
were at least somewhat familiar with exposure for PTSD, only a small minority used it to treat 
PTSD in their clinical practice. Even among psychologists with strong interest and training in 
behavioral treatment for PTSD, exposure therapy is not completely accepted or widely used. 
Clinicians also appear to perceive a significant number of barriers to implementing exposure.  
 
Keywords: PTSD, exposure, cognitive behavioral therapy, survey 
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 Substantial evidence supports the efficacy of exposure therapy for PTSD (Foa, Keane, & 
Friedman, 2000). Yet, as with empirically-supported treatments (ESTs) for many other disorders 
(Barlow, Levitt, & Bufka, 1999), exposure appears to be under-utilized in clinical practice (Foy 
et al., 1996). In one of the few papers to examine the clinical utilization of exposure therapy for 
PTSD, Foy et al. discussed the low utilization of exposure within VA clinics, which are major 
centers for PTSD treatment in the United States. Foy et al. cited unpublished data by Fontana, 
Rosenheck, & Spencer (1993) indicating that exposure was used to treat fewer than 20% of 4000 
veterans with PTSD and that it was used as the primary treatment in only 1% of cases. Foy et al. 
also cited unpublished data (Kagan et al., 1993) indicating that, in a program devoted to 
delivering exposure therapy for veterans with PTSD, exposure was successfully implemented in 
only 38% of cases. The obstacles to implementation in “unsuccessful” cases included psychiatric 
comorbidity (19%), task problems (19%), patient refusal (16%) and medical contraindications 
(8%). Research also suggests that, even among experts, exposure utilization appears to be lower 
than might be expected. In one of the few other reports of exposure therapy utilization, Litz, 
Blake, Gerardi and Keane (1990) reported that exposure was used in only 58% of cases treated 
by 11 nationally recognized experts in the use of exposure therapy for PTSD.  
The limited data on exposure therapy utilization suggest that systematic attention to the 
myriad of factors that can affect clinical use of exposure is warranted, particularly if advocates of 
ESTs want to see exposure therapy implemented on a broader scale in general clinical practice. 
Convincing practitioners to use exposure for PTSD on a routine basis likely will not be an easy 
task. ESTs such as exposure therapy have been a clinical option for a significant period of time, 
and it appears that telling practitioners that such treatments exist and that they should use them 
does not lead to widespread utilization of such interventions. Although the data described by Foy 
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et al. (1996) demonstrate that patient barriers can interfere even when therapists are trained and 
committed to delivering exposure, it is likely that therapist factors play an equally important role 
in determining whether or not exposure therapy for PTSD is widely utilized.  
Several authors have noted that therapists avoid using exposure because they do not 
understand it and/or are uncomfortable with it (Boudewyns & Shipley, 1983; Fontana et al., 
1993, cited in Rogers, 1998). Dissemination of exposure therapy also hinges on other therapist 
factors, such as ease, cost, and availability of training; willingness to receive training; availability 
of supervision; general clinical myths about exposure for PTSD as a whole; and clinical lore and 
personal beliefs about the specific contexts and conditions for its use. In addition, such therapist 
variables as knowledge and comfort may interact with a variety of patient variables, such as 
avoidance or initial worsening of symptoms, to result in low utilization. Finally, professional 
background and theoretical orientation may play a role in the delivery of ESTs such as exposure 
therapy. In the U.S, the majority of clinical services are delivered by private mental health 
practitioners of varying professions, educational experiences, theoretical orientations, and 
opinions about the role of research in clinical practice. Ultimately, the widespread use of 
exposure for PTSD likely will depend more upon their attitudes and beliefs about exposure and 
PTSD than on the opinions of the investigators who develop and test exposure therapy.  
In response to calls for increasing dissemination of ESTs, some investigators have begun 
to examine whether clinicians with limited background in behavior therapy can be trained to 
effectively deliver exposure therapy (Foa, 2001). This research addresses a very important 
question, namely can such therapists learn to do this treatment. Other questions, however, remain 
unanswered, such as whether therapists who can be trained will want to be trained, can be trained 
within real world financial constraints, and will use the intervention routinely once trained. 
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Unfortunately, our impression has been that many clinicians who are trained in exposure do not 
routinely use it with the majority of their PTSD patients. Thus, in addition to adequate training, 
other factors such as trust in the intervention, comfort in administering it, and confidence in 
one’s ability to handle a range of patient reactions to it may be vital prerequisites to therapist use 
of exposure in clinical practice (Litz et al., 1990).  
Clinical reports (Jaycox & Foa, 1996; Pitman et al., 1991) suggest that therapists in 
clinical practice often encounter barriers that may lead them to discontinue use of exposure 
therapy with a particular patient, and/or in general. Although some of the obstacles to 
implementing exposure have been discussed in the literature (Foy et al., 1996; Jaycox & Foa, 
1996; Pitman et al., 1991), data regarding which obstacles most concern clinicians are lacking. 
Similarly, although data from the VA system have corroborated the perception of low utilization 
by VA clinicians, comparable data from civilian practitioners are limited, and it is unclear which 
barriers to implementation pose the most serious problems according to clinicians. 
If exposure therapy is to penetrate the clinical realm, researchers and policy makers must 
understand and address the treatment barriers that are perceived by therapists. As noted by the 
American Psychological Association Task Force for Empirically Validated Treatments, for 
clinicians to value research findings may require that clinicians be “treated as partners in the 
research enterprise” (Task Force on Promotion and Dissemination of Psychological Procedures, 
1995, p. 11). Listening to clinician concerns is an important first step to such a partnership. Yet, 
to our knowledge there have been no published investigations of the clinical utilization of 
exposure for PTSD in civilian clinical practice. Thus far, practitioner concerns have had to be 
gleaned from such sources as the non-empirical literature, informal discussions with practitioners 
who are not research-oriented, informal discussions with scientist practitioners who have left 
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exposure for other cognitive behavioral therapy (CBT) approaches, reactions to workshops and 
presentations on exposure therapy, and the availability of exposure referral options for patients 
with PTSD. Although such communications have been informative, we were interested to know 
whether anecdotal impressions would be substantiated by a systematic study of practitioners’ 
reported use of exposure and opinions about factors that influence their decision to use it.  
The purpose of the present study was to conduct an initial survey of licensed 
psychologists regarding their use of exposure therapy for PTSD and their perceived barriers to its 
implementation. Specifically, we sought to determine the extent to which exposure is being used 
in clinical practice and to identify factors that may influence psychologists’ decision to use it. 
Thus, we surveyed perceived contraindications to using exposure, expected complications that 
might arise from its use, and other factors that might influence psychologists’ use of it. Because 
perceptions and use of exposure likely differ between psychologists with defined interest and 
training in behavioral treatments for PTSD versus clinicians at large, after completing the main 
survey study we conducted a small follow-up study with a distinct sample of behaviorally trained 
psychologists interested in PTSD. We hypothesized that only a minority of the main sample of 
psychologists would report using exposure and that psychologists from this sample would 
endorse a wide variety of perceived contraindications to and complications arising from exposure 
for PTSD. We also hypothesized that a majority of behaviorally trained psychologists with a 
defined interest in PTSD would report using exposure, but that only a minority would report 
using it with all or almost all of their patients. Finally we hypothesized that participants in this 
behaviorally trained sample would continue to endorse a significant number of contraindications 
and complications, although at a lower rate than the main study sample. 
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Method 
Participants 
Main Survey Sample 
  We surveyed a total of 852 psychologists from two rural New England states and two 
urban populations in Texas. Fifty percent (n = 543) of the licensed psychologists in New 
Hampshire and Vermont were randomly selected from listings of doctoral level licensed 
psychologists provided by these states’ licensing boards, and 50% (n = 309) of the licensed and 
provisionally licensed psychologists in San Antonio and Austin were randomly selected from the 
listings provided by the Texas state licensing board. The survey packet contained individually 
addressed cover letters, surveys, and addressed, stamped return envelopes. Psychologists were 
asked to return the surveys within two and a half weeks upon receipt of the survey packet.  
Approximately 200 surveys were mailed every two weeks beginning in November 1999. 
After all of the surveys had been mailed, we distributed follow up letters to the psychologists 
thanking those who had returned the surveys and asking for those who had not yet returned the 
surveys to please do so. Return envelopes were destroyed upon receipt to ensure confidentiality 
and anonymity. Fifteen Texas surveys and 43 New England surveys were undeliverable, and 115 
Texas (39.1%) and 102 New England (20.4%) surveys were returned, yielding an overall 
response rate of 27.3% after undeliverable surveys were subtracted. This response rate is roughly 
comparable to other surveys of licensed psychologists (e.g., 30% in Addis & Krasnow, 2000). 
Behaviorally Trained Sample 
In addition to the main survey, we surveyed a population that we expected would have 
greater familiarity and training in the use of exposure therapy for PTSD. Subsequent to the 
mailing of the main study, we requested permission from the president of the Disaster and 
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Trauma Special Interest Group (D&T SIG) of the Association for Advancement of Behavior 
Therapy (AABT) to survey its members (hereafter referred to as the D&T SIG sample). After 
permission was granted, we surveyed all members of the D&T SIG (n = 50) in the same manner 
as described above. Because many SIG members had a preference for email communication, 
however, an email copy of the survey, along with the standard cover letter, also was sent to the 
D&T SIG list-serve with permission of the list-master. The list-serve email noted that members 
should have received the survey in the mail and that they could answer either via email or 
anonymous hard copy. The email also informed SIG members that upon receipt of email 
responses, we would delete their name, print out an anonymous hard copy and then delete their 
email. This methodology was used to insure as much anonymity as possible with emailed 
surveys. Five surveys were returned to sender. We created a temporary list of these five names 
with the intention of crossing the names off the list if we received an email message from any of 
these members. Because no emailed surveys were received from these members, we counted 
them as undeliverable. Twenty-nine surveys were returned, yielding a response rate of 64.4%.  
Survey Questionnaire  
In addition to investigating rates of exposure utilization, we were interested in identifying 
perceived barriers to the clinical use of exposure. Thus, we completed an exhaustive literature 
search regarding reported difficulties implementing exposure for PTSD and any warnings about 
using exposure with certain types of PTSD patients. After compiling a list of potential barriers, 
we developed a 15-item, 3-page, pencil and paper survey designed to assess the following:  
participants’ familiarity with, training in, comfort with, and actual use of imaginal exposure (IE) 
for PTSD, training in and utilization of in vivo exposure, use of other trauma-focused treatments 
for PTSD, characteristics thought to contraindicate the use of IE for PTSD, perceptions regarding 
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the likelihood of patient problems being exacerbated by exposure, and factors that influence 
decisions to use exposure. In order to minimize confusion regarding the exposure questions and 
because IE is typically considered to be the crucial component of exposure therapy for PTSD, the 
survey focused on IE. Questions about usage of in vivo and other trauma-focused treatment were 
included in order to gain a sense of respondents’ general background with trauma-focused 
interventions. We also assessed characteristics of the respondents, including theoretical 
orientation, primary professional setting, patient hours per week, and number of PTSD patients 
treated. Although closed-ended response categories for each question were devised to facilitate 
data analysis, where appropriate, we included space for additional comments.  
This study was approved by the Trinity University Institutional Review Board. The 
survey was constructed in an iterative process. First, with the assistance of an undergraduate 
student, the first and third authors developed the survey and submitted it to the second author for 
input. After revision the survey was reviewed by a) a nationally recognized PTSD expert and 
then b) a colleague with extensive experience in survey design. After completing revisions based 
on their feedback, we administered pilot surveys to eight licensed psychologists and one 
postdoctoral fellow. Four pilot respondents had expertise in CBT and IE for PTSD. The 
remaining respondents were not trained in CBT and did not have PTSD expertise. In addition to 
completing the survey, pilot participants were asked to provide comments. The final set of 
revisions was completed based on both the responses and feedback of the nine pilot participants. 
Results 
Sample Characteristics 
Main Sample 
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A total of 217 (27.3%) surveys were returned. Ten surveys were unusable as the 
respondents had completed only the demographic questions. These 10 respondents consisted of 4 
school psychologists, 2 industrial organization psychologists, 3 retired psychologists, one 
psychologist who no longer actively practiced, and one psychologist who had “no opinions on 
this issue.”  Thus, the final sample for this study consisted of 207 usable surveys. 
The majority of respondents (58%) endorsed private practice as their primary 
professional setting. Combined, less than 20% worked in medical centers and university settings. 
The mean number of face-to-face patient hours per week was 18.25 (SD = 11.28). The four most 
common self-described theoretical orientations were eclectic (37%), psychodynamic/ analytic 
(28%), behavioral or cognitive-behavioral (CBT; 21.3%), and cognitive (9%).  
D&T SIG 
A total of 29 (64%) D&T SIG members responded to the survey. In contrast to the main 
sample, the majority D&T SIG members endorsed CBT as their primary theoretical orientation 
(76%, n = 22). One member endorsed humanistic and the remainder endorsed eclectic as their 
primary theoretical orientation. Also in contrast to the main sample, only a minority (10%, n = 3) 
endorsed private practice as their primary professional setting. Forty-one percent (n = 12) and 
31% (n = 9) endorsed medical centers and universities respectively as their primary professional 
setting. The mean number of face-to-face patient hours per week was 9.9 (SD = 9.1).  
IE for PTSD: Experience, Training, Familiarity, Comfort, and Use 
 Table 1 shows the number of PTSD patients treated by respondents, the number of 
respondents trained in IE, the different settings in which respondents received IE training, and 
the number of respondents trained in in vivo exposure for PTSD and/or in exposure for other 
anxiety disorders. The majority of the main sample (69%) had not received any formal training 
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in IE for PTSD. In contrast to the main sample, the vast majority of the D&T SIG sample (93%) 
had received formal training in IE for PTSD. The mean number of different types of training in 
IE was 1.7 (SD=1.1) in the main sample and 2.7 (SD=0.8) in the D&T SIG.  
Table 2 shows participants’ reported familiarity and comfort with IE. Combined, 47% of 
the main sample reported that they were “not at all” or only “slightly” familiar with IE for PTSD. 
Only 20% reported being “very familiar.” Participants were instructed to endorse their level of 
comfort with IE only if they were familiar with IE. Of the 207 participants, 85 responded to the 
comfort question. All participants who reported being very familiar with the IE responded to the 
comfort question, but the response rate was lower (57%) among somewhat familiar participants. 
Five slightly familiar participants also responded to this item. Because it seems reasonable to 
conclude that participants who did not respond to this item did not feel very comfortable with the 
treatment, we report percentages based on the total sample. The majority of participants did not 
report feeling comfortable using IE to treat PTSD, and only 10% reported feeling very 
comfortable with IE. In contrast to the main sample, the majority of the D&T SIG sample (86%, 
n = 25) reported being very familiar and very comfortable (72%, n = 21) using IE for PTSD.  
 Table 3 shows rates of utilization of IE. Consistent with our first hypothesis, only 17% of 
respondents in the main sample reported that they currently use IE to treat PTSD. Of the 
respondents who reported use of IE, 52%, or 9% of the total main sample, reported using IE with 
50% or more of their PTSD patients. Only 4% of the total sample reported using IE to treat “all 
or almost all” of their PTSD patients (i.e., 81% or more). Among participants who reported using 
IE, the four most commonly endorsed theoretical orientations were eclectic (34%, n = 12), CBT 
(29%, n = 10), cognitive (17%, n = 6), and psychodynamic (17%, n = 6). 
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Results from the D&T SIG were also consistent with our hypotheses. In contrast to the 
main sample, a majority (66%) of the D&T SIG respondents reported current use of IE to treat 
PTSD. In addition, 84% of respondents who reported using IE (n = 16, 55% of D&T sample) 
indicated that they use IE with 50% or more of their PTSD patients. Yet, only 5 participants 
(17%) reported current use of IE with all or almost all PTSD patients (i.e., 81% or more).  
Although fewer main sample participants reported using in vivo exposure (n = 22, 11%) 
as compared to IE, noticeably more respondents (n = 77, 37%) reported using other trauma-
focused interventions. Participants who reported using other trauma-focused interventions were 
asked to note what interventions they utilized. We report answers that were noted by more than 2 
respondents. Thirty respondents reported using psychodynamic trauma-focused treatment, 14 
reported using other CBT strategies (e.g., cognitive processing therapy, cognitive restructuring), 
14 reported using Eye Movement Desensitization Reprocessing therapy (EMDR), and 7 reported 
using hypnosis. Slightly fewer D&T SIG participants reported using in vivo exposure (59%, n = 
17) and other trauma-focused treatments (55%, n = 16) as compared to IE. Of the respondents in 
the latter group, 6 reported using cognitive therapy and 5 reported using EMDR.  
As noted above, a significant portion of participants in the main sample reported no 
training in IE. Because one would assume a low rate of utilization among untrained clinicians, 
we decided to conduct a post-hoc examination of IE use among those trained in IE. Similarly, 
because PTSD experience might influence participants’ use of IE, we also conducted a post-hoc 
examination of current use of IE among the participants who reported being experienced in the 
treatment of PTSD (i.e., had treated a significant number of PTSD patients). Table 3 reflects 
these analyses. Fifty-nine participants reported formal IE training. Respondents trained in IE 
were significantly more likely to report current IE use as compared to untrained respondents,     
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χ
2 (1, N = 206) = 83.45, p < .001. Of the trained participants, 54% reported currently using IE 
and 29% reported using it to treat 50% or more of their PTSD patients. We assume that the 3 
respondents who reported using IE but did not report formal training in IE were self-trained. 
Only 15% of formally trained respondents reported using IE with 81% or more of their patients.  
Seventy-four respondents reported that they had treated 26 or more patients with PTSD 
and were classified as very experienced in PTSD treatment. Experienced PTSD clinicians were 
also significantly more likely to report currently using IE as compared to participants with less 
PTSD experience, χ2 (2, N = 194) = 32.97, p < .001. Only 3% of participants who had seen fewer 
than 10 PTSD cases and 10% of those who had seen 11-25 cases reported current use. In 
contrast, 37% of the more experienced clinicians reported currently using IE to treat PTSD. Only 
20%, however, reported using IE with 50% or more of their PTSD patients. 
Perceived Contraindications to the Use of IE 
 Participants were asked to respond to 20 factors which, based on the PTSD literature, 
might be viewed as potential contraindications to using IE. These factors included: comorbid 
psychotic disorder, dissociative identity disorder (DID), bipolar disorder, anxiety disorder, or any 
comorbid disorder; severe suicidality, dissociation, or depression; any suicidality, dissociation, or 
depression; physical aggression by patient; physical aggression by other to patient; homicidality; 
low social support; substance abuse/dependence; severe anger; severe numbing; past adherence 
problems; and past treatment non-response. Participants rated the likelihood that each factor 
would contraindicate the use of IE. Thus, participants who believed that a given contraindication 
was not a problem rated it as very unlikely to contraindicate IE. Respondents who were not at all 
familiar with IE were instructed to skip this item, and all such main sample respondents did 
appropriately skip out. Of the 207 participants in the main sample, 105 responded to at least one 
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item in this question and comprise the main sample for this analysis. Because of the volume of 
data produced by this question, we collapsed the “somewhat likely” and “very likely” categories.  
Overall, both samples highly endorsed factors that one would expect to be endorsed as 
contraindicating IE1. For example, factors that are frequently exclusion criteria for randomized 
clinical trials (RCTs) of PTSD were generally rated as likely contraindications, including: severe 
suicidality (main sample = 85%, D&T SIG = 79%), comorbid psychotic disorder (main sample = 
85%, D&T SIG = 76%) and homicidality (main sample = 81%, D&T SIG = 62%). Overall, D&T 
SIG members endorsed fewer contraindications as likely as compared to the main sample. 
Consistent with our contraindication hypotheses, the mean number of likely contraindications 
endorsed by D&T SIG respondents was 7.5 (SD=4.8), which was significantly less than the 
number endorsed by the main sample (M=11.7, SD=5.3), t(131) = 3.88, p<.001. 
Although many expected contraindications were highly endorsed, there were some 
unexpected findings. For example, a relatively large number of main sample respondents also 
endorsed such factors as any dissociation (51%), any comorbid diagnosis (37%), and a comorbid 
anxiety disorder (32%). Yet, surprisingly few respondents in both samples endorsed severe anger 
(main sample = 54%, D&T SIG = 21%), which empirical research has shown to be a risk factor 
for poor response to IE (Foa, Riggs, Massie, & Yarczower, 1995). Similarly, surprisingly few 
respondents endorsed physical aggression by other to patient (main sample = 52%, D&T SIG = 
35%), which is often an exclusion criteria in randomized clinical trials (RCTs) for PTSD. 
To examine the influence of such factors as comfort and familiarity with IE on perceived 
contraindications, we totaled the number of contraindicating factors that each main sample 
respondent identified as likely. Oneway ANOVAs were used to determine whether the number 
of perceived likely contraindications was influenced by familiarity and comfort with IE, training 
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in IE, experience with PTSD, and theoretical orientation. Because a total of five analyses were 
performed, a Bonferroni correction was used to adjust the criterion for statistical significance for 
the ANOVAs to .01 to maintain family-wise error probability at .05 (Kirk, 1968).  
Ninety-nine percent of respondents (n = 104) endorsed at least one contraindication as 
likely. There were no significant differences in the number of perceived contraindications based 
on familiarity with IE, F(2, 102)=2.59, ns, comfort with IE, F(3, 64)=2.44, ns, or the number of 
different ways trained, F(5,99)=.50, ns. There was a significant difference in the number of 
perceived contraindications based on experience in treating PTSD, F(3,99)=4.10, p<.01. Post-
hoc Tukey HSD analyses indicated that participants who reported treating between 26-50 
patients with PTSD endorsed significantly fewer contraindications (M=7.6, SD=5.6) than 
participants who had treated fewer than 10 PTSD patients (M=12.9, SD=4.5) or greater than 50 
PTSD patients (M=12.5, SD=5.7). Because IE for PTSD is a behavioral intervention, we also 
compared the number of perceived contraindications reported by participants who self-identified 
their orientation as CBT (M=10.0, SD=5.9) to the number reported by all other participants 
(M=12.1, SD=5.1). There was no significant difference based on orientation, F(1,103)=3.13, ns. 
Results of analyses were essentially unchanged when the number of very likely perceived 
contraindications was used instead of likely contraindications. 
Potential Complications Resulting from the Use of IE 
Participants were asked to respond to 14 potential negative results (complications) that 
have been discussed in the literature on IE for PTSD. The complications included an increase in 
re-experiencing, avoidance, or arousal symptoms; dissociation; substance abuse/dependence; 
overwhelming anxiety; numbing; self injury; suicidality; homicidality; desire to drop out of 
therapy; physical aggression; relationship problems; and a worsening of the therapeutic alliance. 
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Respondents who were not at all familiar with IE were instructed to skip this item, and all such 
respondents in the main sample did skip out. Of the 207 participants in the main sample, 108 
responded to at least one item in this question and comprise the sample for this analysis. As with 
the previous item, we collapsed the “somewhat likely” and “very likely” categories.  
The complications most commonly endorsed as likely were increases in arousal (main 
sample = 87%, D&T SIG = 55%), re-experiencing symptoms (main sample = 83%, D&T SIG = 
62%), dissociation (main sample = 76%, D&T SIG = 41%), substance abuse (main sample = 
75%, D&T SIG = 51%), and suicidality (main sample = 75%, 45% = D&T SIG)1.  Concerns 
about self-injury and drop-out are often mentioned in relation to IE and are likely to be of great 
concern to clinicians.  Sixty-eight percent of the main sample and 48% of the D&T SIG reported 
that they believed that self-injury was likely to be exacerbated by IE, and 59% and 48% of the 
main sample and D&T SIG respectively believed that IE was likely to increase patients’ desire to 
drop out of therapy.  Overall, D&T SIG members were less inclined than the respondents in the 
main sample to endorse complications as likely. The mean number of likely complications was 
5.8 (SD=4.8), which was significantly less than the number endorsed by the main sample 
(M=9.2, SD=4.0), t(133) = 4.25, p<.001.  
  As above, we totaled the number of problems each main sample respondent rated as 
“likely” to be made worse by the use of IE. Oneway ANOVAs employing a Bonferroni 
correction were used in the main sample to determine the influence of familiarity and comfort, 
training, experience, and theoretical orientation on perceived complications. There were no 
significant differences in the number of perceived likely complications based on familiarity, F(3, 
104)=1.62, ns; comfort, F(3, 68)=3.70, ns; training, F(5,102)=1.83, ns; PTSD experience, 
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F(3,102)=.17, ns; or theoretical orientation, F(1,106)=.06, ns. Results of analyses did not differ 
when the number of very likely negative outcomes was used instead of likely negative outcomes. 
Factors Influencing the Decision to Use IE for PTSD 
Participants were asked to identify factors that might limit their use of IE by checking 
items that influenced their decision to use IE. The three most commonly endorsed factors in the 
main sample were limited training (60%, n = 124), a preference for individualized treatment over 
manualized therapy (25%, n = 52), and concern that the patient would decompensate (22%, n = 
45)1. Because IE use was low even among trained participants, we separately examined the data 
from respondents who reported being trained in IE but who were not currently using IE (n = 27). 
The three most commonly endorsed factors among these respondents were lack of training (40%, 
n = 11), concern that the patient would decompensate (35%, n = 9), and a preference for 
individualized treatment over manualized therapy (31%, n = 8). D&T SIG members endorsed 
fewer factors as compared to the main sample. Only four items were endorsed by more than one 
of the D&T SIG members and none were endorsed by even 20% of the sample.   
Because it is possible that limited training is a greater problem for non-behaviorally 
trained clinicians, we examined the main sample data to see if behaviorally trained clinicians 
appeared less likely to consider training a limiting factor. Over 50% of participants in each of the 
four most commonly endorsed theoretical orientations, including behavioral, reported that lack 
of training was a limiting factor in their use of IE (eclectic 59%, n = 45; psychodynamic 64%, n 
= 37; behavioral/CBT 52%, n = 23; cognitive 50%, n = 9), and the difference between groups 
was not significant χ2 (3, N = 167) = 1.83, ns. 
Discussion 
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Proponents of empirically-supported interventions, particularly cognitive behavioral 
therapies, have increasingly turned from the task of developing and testing interventions to the 
task of trying to disseminate them to practitioners in the general mental health community. 
Several authors have discussed the potential barriers to achieving widespread use of empirically-
supported interventions (e.g., Barlow et al., 1999). Studies that investigate factors affecting 
clinical utilization of empirically-supported interventions have the potential to greatly inform the 
dissemination process. Such studies (e.g., Mussell et al., 2000) are, however, few in number.  
The primary objective of the present study was to investigate psychologists’ self-reported 
rates of utilization of IE for PTSD. The main survey results indicate that a large majority of 
licensed psychologists in clinical practice are not using IE to treat their PTSD patients. Although 
approximately half of the main sample reported that they were at least somewhat familiar with IE 
for PTSD, only a small minority (17%) used it to treat PTSD. To some extent, the low utilization 
might be due to lack of training, since less than one third of the main sample reported that they 
had received formal training in IE. Lack of training was also the most commonly endorsed 
limiting factor among participants in the main sample. Issues in training in ESTs have been 
extensively discussed by the Task Force on Promotion and Dissemination of Psychological 
Procedures (1995). As noted by the Task Force, the typical 3-hour to 3-day workshop is 
insufficient to introduce a new area of competency. Opportunities for more intensive training and 
for ongoing supervision are clearly needed if clinicians are to add IE to their clinical repertoire. 
Yet, only about half of those who had received training reported using IE to treat PTSD, and less 
than a third of those trained used it to treat at least half of their PTSD patients. This suggests that 
factors other than training also may be influencing the use of IE for PTSD. 
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Higher utilization rates reported by participants who were both trained and experienced in 
the treatment of PTSD (over 65% for both samples) suggest that experience with PTSD may 
interact with IE training. These rates are double that reported by participants who were trained 
but had less experience. Yet, even among participants who are both trained and experienced with 
PTSD, utilization remains disappointingly low. Less than half of the trained and experienced 
participants in the main sample reported using the intervention with 50% or more of their 
patients, and almost one third did not use IE at all. Utilization among the D&T SIG sample was 
also surprisingly low given that the large majority of this sample had received training and nearly 
three quarters reported being “very comfortable” with IE for PTSD. Fully one third of this 
sample indicated that they do not currently use IE and only slightly more than half reported that 
they use IE with at least half of their patients with PTSD. Moreover, even in this highly trained 
sample only a small portion (17%) reported current use of IE with almost all their PTSD patients.  
Nearly twice as many main sample participants reported formal training in IE for PTSD 
(29%) as compared to exposure for other anxiety disorders (13%). Similarly, whereas 93% of the 
D&T SIG respondents reported formal training in IE, only 45% reported formal training in 
exposure for other anxiety disorders. Thus, it appears that many psychologists have received 
specialized training in PTSD exposure without obtaining training in the use of exposure for other 
anxiety disorders. This was sobering given the wealth of evidence supporting the use of exposure 
interventions for other anxiety disorders and how long these interventions have been available.  
The limited training in exposure for anxiety disorders is problematic for two reasons. 
First, we believe that gaining experience in the use of exposure for other anxiety disorders can 
help therapists develop familiarity, comfort, and confidence in the use of exposure generally, 
before applying it to PTSD (Zayfert, Becker, & Gillock, 2002). Second, as many as 74% percent 
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of patients seeking treatment for PTSD will evidence a comorbid anxiety disorder (Zayfert, 
Becker, Unger, & Shearer, 2002). The extent of generalization of trauma-focused exposure work 
to comorbid anxiety disorders is not known, and comorbid anxiety disorders often may require 
focused exposure beyond IE for PTSD (e.g., Becker, 2002). Cognitive-behavioral practitioners 
who are unfamiliar with methods of delivering exposure for other anxiety disorders may not be 
prepared to address the range of problems presented by PTSD patients. 
Understanding practitioner perceptions of barriers to using IE may inform efforts to 
promote greater use of IE in clinical practice. Thus, a second aim of this study was to identify 
perceived barriers and other factors that might influence the decision to use IE. Factors that 
frequently are exclusions for RCTs of IE (e.g., severe suicidality, homicidality, psychotic 
disorder) were widely endorsed as contraindications by both samples. The main sample also a) 
endorsed other factors (any dissociation, any comorbid disorder) which have not been overtly 
excluded from randomized trials and b) indicated that they believed that IE was likely to lead to 
an increase in symptoms or problems in therapy such as a worsening in suicidality or substance 
abuse/dependence. Similarly, more than half of the sample believed that patients would 
experience an increased desire to drop out of therapy as a result of using IE. The overall high 
endorsement of such contraindications and complications is disturbing, particularly given the 
finding that such perceptions did not vary according to training, familiarity, comfort, or 
theoretical orientation.  This suggests that beliefs about contraindications and complications are 
not limited to those unfamiliar with IE or non-behavioral therapists.  Such perceptions likely 
represent real barriers to the dissemination of exposure for PTSD and need to be addressed.   
On the whole, the psychologists in both samples surveyed endorsed many likely 
contraindications to using IE (M = 11.7 for the main sample and 7.5 for D&T SIG). We view this 
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as troubling for two reasons. First, when Frueh, Mirabella and Turner (1995) investigated the 
effect of implementing the seven contraindications generated by the experts in the Litz et al. 
(1990) study, they found that 73% of PTSD patients coming to a VA clinic would be excluded. 
As Frueh et al. noted, virtually none of the contraindications were empirically based. Frueh et al. 
encouraged clinicians to not categorically exclude all patients who displayed one or more of the 
contraindications and to consider that “creative engineering” of exposure might enable the 
application of IE to a broader population. The results of the present study raise concerns similar 
to those implied by Frueh et al. Namely, that many patients who could benefit from exposure are 
inappropriately being excluded based on clinician beliefs that IE is associated with an extensive 
list of contraindications. It should be recognized that clinicians are likely responding to clinical 
lore since the list of contraindications used in the present study was generated by the literature on 
PTSD and trauma focused treatment. Research that establishes which factors truly contraindicate 
the use of IE is needed. In the meantime, however, teaching clinicians how to “creatively 
engineer” IE would likely be helpful in reducing the number of perceived contraindications and 
in potentially changing some of the clinical lore regarding IE and PTSD. In addition, it is 
important that future research provide clear recommendations for handling “contraindications” 
and discuss when and whether IE should be used after addressing such obstacles.  
The results from this survey suggest that clinicians also may sometimes use IE in the 
presence of real contraindications that are discussed in the literature and often result in exclusion 
from RCTs. Negative experiences with using IE may significantly affect future use of IE because 
use of IE in the presence of contraindicating factors may result in poor outcomes and thereby 
discourage future use. For example, a surprisingly low percentage of both the main sample and 
the D&T SIG endorsed physical aggression by other to patient (53 and 35% respectively) as a 
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contraindication. Current physical abuse is, with good reason, often an exclusionary criterion for 
admission to RCTs of CBT for PTSD (Foa et al., 1999; Foa, Rothbaum, Riggs, & Murdock, 
1991; Resick, Nishith, Weaver, Astin, & Feuer, 2002). Ongoing physical aggression presents a 
significant obstacle for PTSD treatment because the hypervigilance and arousal associated with 
PTSD may be an adaptive reaction to real danger. The focus of therapy under these conditions 
should be on establishing current safety rather than decreasing vigilance to actual threats. 
Severe anger also was endorsed as a contraindication by a relatively low proportion of 
respondents in both samples (54 and 21% respectively). Although severe anger has not been an 
exclusion criterion in randomized trials, empirical research has shown that anger is a risk factor 
for poor response to IE (Foa, Riggs, Massie, & Yarczower, 1995). Supplemental strategies for 
handling severe anger prior to using IE have been discussed in the literature (Becker & Zayfert, 
2001; Jaycox & Foa, 1996). On the one hand the anger finding may be viewed as positive, 
indicating a willingness to use IE once anger has been addressed with supplemental strategies. 
On the other hand, however, low endorsement of anger as a contraindication might indicate that 
many clinicians are unfamiliar with the empirical and theoretical literature on IE and anger. If a 
practitioner uses IE with individuals who evidence severe anger and observes an unfavorable 
outcome, he or she might abandon the use of IE for PTSD altogether.  
Results from the D&T SIG members indicate that although they perceive a number of 
contraindications and complications, they do so to a lesser degree than participants in the main 
sample. This suggests that practitioners with more training and experience with CBT generally, 
and IE for PTSD specifically, may have more confidence in the broader utility of exposure for 
ameliorating anxiety and PTSD symptoms. D&T SIG clinicians differ from the main sample in a 
number of significant ways, however, in that they have a special interest in PTSD, their 
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participation in AABT likely indicates an increased interest in research as compared to clinicians 
at large, and a greater number are primarily located in universities and medical centers. This 
suggests that addressing the IE concerns of members of the D&T SIG likely will not be sufficient 
to significantly increase the use of IE in the general mental health community because D&T SIG 
members did not appear to be representative of psychologists at large.  
Despite the differences between the samples, it is important to note that nearly half of the 
D&T SIG endorsed an increase in desire to drop out of therapy as likely to occur from using IE 
for PTSD. Thus, even clinicians with the most training and interest in behavior therapy for PTSD 
have concerns about how patients react to the use of IE.  A noteworthy number of members 
endorsed a wide range of contraindications and complications, and only a small minority use IE 
to treat the vast majority of their patients with PTSD.  Thus, although it may be insufficient to 
simply attend to the concerns of the D&T SIG members, members did express significant 
concerns which likely need to be addressed. 
Several limitations to the present study need to be acknowledged. Although an effort was 
made to sample from both rural and urban practicing psychologists, the sample was limited to 
three states, and therefore, the survey may not be representative of the population of practicing 
psychologists in the U.S. Yet, as with Addis and Krasnow’s (2000) large national survey of 
practicing psychologists, 58% of our main sample reported that their primary professional setting 
was private practice (compared to 56% in Addis and Krasnow). This provides some limited 
support for the generalizability of the present sample.  
The response rate of 27.3% in the present study was somewhat lower than some other 
surveys of psychologists (e.g., 55% in Mussell et al., 2000). D&T SIG members had a markedly 
higher response rate than the main sample. Although this might be a result of the email response 
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option, it could also indicate that clinicians who are familiar with IE might have been more likely 
to respond to the survey. Thus, it seems important to recognize that community respondents to 
this survey may present an overly optimistic picture of exposure utilization. In addition, we only 
sampled psychologists. Psychologists, due to their scientist-practitioner training, might be more 
inclined to utilize ESTs than other mental health practitioners. Although the generalizability of 
these findings to the universe of mental health practitioners may be limited, it is reasonable to 
assume that IE would be used less by practitioners of other professions. 
With regard to rates of exposure utilization, this study provides self-report data of 
practice behavior, and as such may not accurately reflect actual practice. When we began 
systematically tracking our own practice behavior, we were surprised to find that we had actually 
used IE with fewer of our patients than we had intended to (Zayfert & Becker, 2000). Based on 
our experience, we expect that self-report of practice rates by psychologists with positive 
attitudes towards IE may in fact overestimate actual rates of utilization.  
In summary, exposure for PTSD appears to be under-utilized in clinical practice. Even 
among psychologists with strong interest and training in behavioral treatments for PTSD, IE is 
not completely accepted or widely used. Clinicians appear to perceive a significant number of 
barriers to implementing exposure. Further research is needed to determine which complications 
are likely and which contraindications are valid. Nonetheless, clinicians in general practice may 
not change their perceptions solely based on such research. Greater dialog between clinicians and 
researchers may validate clinician concerns and open the door to developing and studying 
creative methods for facilitating the use of exposure therapy for PTSD.  
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Footnotes 
1
 A table providing a full breakdown of data for this item is available upon request 
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Table 1 
PTSD and Exposure Experience 
 Main Sample 
(n = 207) 
 D&T SIG 
(n = 29) 
Number of PTSD patients treated n %  n % 
   Less than 10 76 36.7  6 20.6 
   11-25 44 21.3  7 24.1 
   26-50 25 12.1  3 10.3 
   50+ 49 23.7  13 44.8 
Trained in imaginal exposure 59 28.5  27 93.1 
   CE workshop 27 13.0  9 31.0 
   Graduate school 16 7.7  12 41.4 
   Internship 14 6.7  10 34.4 
   Formal postdoctoral fellowship  7 3.4  5 17.2 
   Informal postdoctoral fellowship 10 4.8  4 13.8 
   Other  8 3.8  6 20.1 
Trained in in vivo exposure for 
PTSD  
56 27.1  22 75.9 
Trained in exposure for other 
anxiety disorders 
26 12.5  13 44.8 
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Table 2 
Familiarity & Comfort with Imaginal Exposure 
 Main sample 
(n = 207) 
 D&T SIG 
(n = 29) 
Familiarity n %  n % 
   Not at all  50 24.2  1  3.4 
   Slightly 48 23.2  0  0.0 
   Somewhat 67 32.4  3 10.3 
   Very 42 20.3  25 86.2 
Comfort       
   Not at alla 149 72.0  2 6.9 
   Slightly 16  7.7  0 0.0 
   Somewhat 21 10.1   6 20.7 
   Very 21 10.1  21 72.4 
 
aThis category also includes participants who did not respond to this question but who endorsed 
lack of familiarity with imaginal exposure. It is assumed that participants who are not familiar 
with a treatment are not comfortable implementing it. 
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Table 3 
Utilization of Imaginal Exposure 
 Main 
sample 
Main sample by training & experience D&T SIG 
 
 Total 
(n = 207) 
No training 
(n = 148) 
Trained 
(n = 59) 
 
(n = 29) 
  
Less Exp     
(n = 108)  
More Exp 
(n = 40) 
Less Exp 
(n = 25) 
More Exp 
(n = 34) 
 
 
Patients treated 
with imaginal 
exposure 
 
 
n 
 
 
% 
 
 
n 
 
 
% 
 
 
n 
 
 
% 
 
 
n 
 
 
% 
 
 
n 
 
 
% 
 
 
n 
 
 
% 
   None 172 83.1 108 100.0 37 92.5 16 68.0 11 32.4 10 34.5 
   <50% 17 8.2 0 0.0 2 5.0 6 20.0 9 26.5 3 10.3 
    50-80% 9 4.3 0 0.0 1 2.5 2 8.0 6 17.6 11 37.9 
   81% or more 9 4.3 0 0.0 0 0.0 1 4.0 8 23.5 5 17.2 
 
Note. Less Exp = Less Experience, More Exp = More Experience. Clinicians with less 
experience reported having treating 25 or fewer PTSD patients. More experienced clinicians 
reported treating 26 or more PTSD patients. 
 
   
 
